Insider · CIK 0001865136

OConnell Daniel Joseph

Reports to the SEC for 1 company · NEWTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001865136

Forms 4 and 5

Insider transactions

27 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-22	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,689 sh	$1.88	−$5,065.538	881,275
2026-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,346 sh	$1.81	−$16.9K	883,964
2026-01-20	ABOSAcumen Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	893,310
2026-01-20	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+450K sh	—	—	450,000
2026-01-12	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,388 sh	$1.73	−$9,306.692	593,510
2026-01-09	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−12.9K sh	$1.76	−$22.8K	598,898
2026-01-08	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,143 sh	$1.82	−$14.8K	611,839
2026-01-07	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−37.8K sh	$1.99	−$75K	619,982
2026-01-06	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,102 sh	$1.97	−$10K	657,737
2026-01-05	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,649 sh	$1.97	−$9,163.179	662,839
2025-01-21	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−12.6K sh	$1.59	−$20.1K	667,488
2025-01-07	ABOSAcumen Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+225K sh	—	—	680,107
2025-01-07	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+338K sh	—	—	338,000
2025-01-03	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−47.8K sh	$1.84	−$87.9K	454,707
2024-01-19	ABOSAcumen Pharmaceuticals, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.2K sh	$3.47	−$52.8K	502,485
2024-01-02	ABOSAcumen Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+401K sh	—	—	517,685
2024-01-02	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+602K sh	—	—	602,000
2023-01-17	ABOSAcumen Pharmaceuticals, Inc.A Award	Director, Chief Executive Officer	AAward	+114K sh	—	—	116,685
2023-01-17	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+473K sh	—	—	472,500
2022-01-19	ABOSAcumen Pharmaceuticals, Inc. · Employee Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+455K sh	—	—	455,000
2021-11-30	ABOSAcumen Pharmaceuticals, Inc.M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+1,118 sh	$4.47	+$4,997.46	2,685
2021-11-30	ABOSAcumen Pharmaceuticals, Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−1,118 sh	—	—	0
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.C Conversion	Director, Chief Executive Officer	CConversion	+123 sh	—	—	1,542
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.X Exercise of In-Money	Director, Chief Executive Officer	XExercise of In-Money	+35 sh	$4.47	+$156.45	1,577
2021-07-06	ABOSAcumen Pharmaceuticals, Inc.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−10 sh	$16.00	−$160	1,567
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Series A Preferred StockC Conversion	Director, Chief Executive Officer	CConversion	−123 sh	—	—	0
2021-07-06	ABOSAcumen Pharmaceuticals, Inc. · Warrant (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−35 sh	—	—	0

Recent filings

Accepted (ET)
Jan 234
OConnell Daniel Joseph0001628280-26-003346
SEC(opens sec.gov)
Jan 214
OConnell Daniel Joseph0001628280-26-002962
SEC(opens sec.gov)
Jan 124
OConnell Daniel Joseph0001628280-26-001895
SEC(opens sec.gov)
Jan 74
OConnell Daniel Joseph0001628280-26-001263
SEC(opens sec.gov)
Jan 234
OConnell Daniel Joseph0001576885-25-000035
SEC(opens sec.gov)
Jan 74
OConnell Daniel Joseph0001576885-25-000021
SEC(opens sec.gov)
Jan 194
OConnell Daniel Joseph0001576885-24-000029
SEC(opens sec.gov)
Jan 44
OConnell Daniel Joseph0001576885-24-000009
SEC(opens sec.gov)
Jan 184
OConnell Daniel Joseph0001209191-23-003741
SEC(opens sec.gov)
Jan 214
OConnell Daniel Joseph0001209191-22-004419
SEC(opens sec.gov)

Companies

Acumen Pharmaceuticals, Inc.Director, Chief Executive OfficerABOS

Address

C/O ACUMEN PHARMACEUTICALS, INC. 1210-1220 WASHINGTON STREET, SUITE 210

NEWTON, MA, 02465